GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 701 filers reported holding GLAXOSMITHKLINE PLC in Q3 2014. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $113,164,000 | -0.7% | 2,623,782 | -0.2% | 3.61% | +1.7% |
Q2 2016 | $113,947,000 | +16.3% | 2,629,138 | +8.8% | 3.55% | +21.9% |
Q1 2016 | $97,951,000 | +1.8% | 2,415,570 | +1.3% | 2.91% | +1.6% |
Q4 2015 | $96,197,000 | +58.0% | 2,384,060 | +50.6% | 2.87% | +56.9% |
Q3 2015 | $60,883,000 | -11.6% | 1,583,431 | -4.3% | 1.83% | -3.4% |
Q2 2015 | $68,898,000 | -7.2% | 1,654,203 | +2.8% | 1.89% | -1.3% |
Q1 2015 | $74,255,000 | +21.2% | 1,609,002 | +12.2% | 1.92% | +17.8% |
Q4 2014 | $61,267,000 | -9.1% | 1,433,473 | -2.2% | 1.63% | -13.6% |
Q3 2014 | $67,410,000 | -9.4% | 1,466,396 | +5.3% | 1.88% | -6.8% |
Q2 2014 | $74,441,000 | +15.2% | 1,391,936 | +15.1% | 2.02% | -0.1% |
Q1 2014 | $64,633,000 | +13.2% | 1,209,685 | +13.1% | 2.02% | -2.7% |
Q4 2013 | $57,114,000 | -46.4% | 1,069,750 | -49.7% | 2.08% | -1.1% |
Q3 2013 | $106,652,000 | +111.9% | 2,125,828 | +111.0% | 2.10% | +2.3% |
Q2 2013 | $50,342,000 | – | 1,007,440 | – | 2.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SENZAR ASSET MANAGEMENT, LLC | 668,200 | $30,717,000 | 9.01% |
Camber Capital Management LP | 1,200,000 | $55,164,000 | 5.18% |
Camber Capital Management LP | 1,000,000 | $45,970,000 | 4.32% |
Gary Goldberg Planning Services Inc | 178,496 | $8,205,000 | 3.41% |
Hamlin Capital Management, LLC | 1,217,870 | $55,985,000 | 3.36% |
Winch Advisory Services, LLC | 109,101 | $5,015,000 | 3.22% |
NORTHROAD CAPITAL MANAGEMENT LLC | 151,701 | $6,974,000 | 2.69% |
Reynders McVeigh Capital Management, LLC | 296,118 | $13,613,000 | 2.59% |
SALEM CAPITAL MANAGEMENT INC | 120,520 | $5,540,000 | 2.58% |
Keystone Financial Planning, Inc. | 74,338 | $3,417,000 | 2.58% |